Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. Academic Article uri icon

Overview

abstract

  • PURPOSE: Patient-reported outcomes are increasingly used in routine outpatient cancer care to guide clinical decisions and enhance communication. Prior evidence suggests good patient compliance with reporting at scheduled clinic visits, but there is limited evidence about compliance with long-term longitudinal reporting between visits. PATIENTS AND METHODS: Patients receiving chemotherapy for lung, gynecologic, genitourinary, or breast cancer at a tertiary cancer center, with access to a home computer and prior e-mail experience, were asked to self-report seven symptomatic toxicities via the Web between visits. E-mail reminders were sent to participants weekly; patient-reported high-grade toxicities triggered e-mail alerts to nurses; printed reports were provided to oncologists at visits. A priori threshold criteria were set to determine if this data collection approach merited further development based on monthly (≥ 75% participants reporting at least once per month on average) and weekly compliance rates (60% at least once per week). RESULTS: Between September 2006 and November 2010, 286 patients were enrolled (64% were women; 88% were white; median age, 58 years). Mean follow-up was 34 weeks (range, 2 to 214). On average, monthly compliance was 83%, and weekly compliance was 62%, without attrition until the month before death. Greater compliance was associated with older age and higher education but not with performance status. Compliance was greatest during the initial 12 weeks. Symptomatic illness and technical problems were rarely barriers to compliance. CONCLUSION: Monthly compliance with home Web reporting was high, but weekly compliance was lower, warranting strategies to enhance compliance in routine care settings.

publication date

  • June 3, 2013

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Drug-Related Side Effects and Adverse Reactions
  • Internet
  • Neoplasms
  • Self Report

Identity

PubMed Central ID

  • PMC3699724

Scopus Document Identifier

  • 84883855864

Digital Object Identifier (DOI)

  • 10.1200/JCO.2012.47.6804

PubMed ID

  • 23733753

Additional Document Info

volume

  • 31

issue

  • 20